tiprankstipranks
Advertisement
Advertisement
Jacobio’s JAB-2485 Trial Progress: Early Cancer Data in Focus for HK:1167 Investors
PremiumCompany AnnouncementsJacobio’s JAB-2485 Trial Progress: Early Cancer Data in Focus for HK:1167 Investors
3M ago
Jacobio Strikes Up to US$1.9 Billion Global KRAS Inhibitor Deal With AstraZeneca
Premium
Company Announcements
Jacobio Strikes Up to US$1.9 Billion Global KRAS Inhibitor Deal With AstraZeneca
4M ago
Jacobio Pharmaceuticals Secures RMB125 Million to Advance Oncology Pipeline
Premium
Company Announcements
Jacobio Pharmaceuticals Secures RMB125 Million to Advance Oncology Pipeline
4M ago
Jacobio Pharmaceuticals Advances Cancer Treatment with JAB-30355 Study
PremiumCompany AnnouncementsJacobio Pharmaceuticals Advances Cancer Treatment with JAB-30355 Study
5M ago
Jacobio Pharmaceuticals Unveils Promising Preclinical Data for Pan-KRAS Inhibitor
Premium
Company Announcements
Jacobio Pharmaceuticals Unveils Promising Preclinical Data for Pan-KRAS Inhibitor
6M ago
Jacobio Pharmaceuticals Advances Strategic Focus with Capital Increase and Equity Transfer
Premium
Company Announcements
Jacobio Pharmaceuticals Advances Strategic Focus with Capital Increase and Equity Transfer
6M ago
Jacobio Pharmaceuticals Announces Board Meeting for Interim Results
PremiumCompany AnnouncementsJacobio Pharmaceuticals Announces Board Meeting for Interim Results
8M ago
Jacobio Pharmaceuticals Increases Concert Parties’ Shareholdings
Premium
Company Announcements
Jacobio Pharmaceuticals Increases Concert Parties’ Shareholdings
8M ago
Jacobio Pharmaceuticals Increases Concert Parties’ Shareholdings
Premium
Company Announcements
Jacobio Pharmaceuticals Increases Concert Parties’ Shareholdings
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100